Elevated plasma ferritin is associated with increased incidence of type 2 diabetes in middle-aged and elderly Chinese adults

Journal of Nutrition

Volumn 143, Issue 9, 2013, Pages 1459-1465

  Sun, Liang ^a   Zong, Geng ^a   Pan, An ^b   Ye, Xingwang ^a   Li, Huaixing ^a   Yu, Zhijie ^c   Zhao, Yao ^d   Zou, Shurong ^e   Yu, Danxia ^f   Jin, Qianlu ^a   Hu, Frank B ^g   Lin, Xu ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c BROCK UNIVERSITY   (Canada)

^d Centers for Preventive Medical Research   (China)

^e SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE;

ADULT; AGED; ARTICLE; BODY MASS; CHINESE; DISEASE ASSOCIATION; DISEASE MARKER; DOSE RESPONSE; DRINKING BEHAVIOR; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; INCIDENCE; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RURAL AREA; SELF REPORT; URBAN AREA;

ADIPONECTIN; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; FERRITINS; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84883292664     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.113.177808     Document Type: Article

References (50)

1. Pan XR, Yang WY, Li GW, Liu J. Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care. 1997;20:1664-9.
2. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, Shan Z, Liu J, Tian H, Ji Q, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090-101.
3. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129-40.
4. Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care. 2011;34:1249-57.
5. Halliwell B, Gutteridge J. Protection against oxidants in biological systems: the superoxide theory of oxygen toxicity. New York: Oxford University Press, 1989.
6. Cooksey RC, Jouihan HA, Ajioka RS, Hazel MW, Jones DL, Kushner JP, McClain DA. Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology. 2004;145:5305-12.
7. Oberley LW. Free radicals and diabetes. Free Radic Biol Med. 1988;5: 113-24.
8. Salonen JT, Tuomainen TP, Nyyssonen K, Lakka HM, Punnonen K. Relation between iron stores and non-insulin dependent diabetes in men: case-control study. BMJ. 1998;317:727.
9. Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA. 2004;291:711-7.
10. Forouhi NG, Harding AH, Allison M, Sandhu MS, Welch A, Luben R, Bingham S, Khaw KT, Wareham NJ. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia. 2007;50:949-56.
11. Montonen J, Boeing H, Steffen A, Lehmann R, Fritsche A, Joost HG, Schulze MB, Pischon T. Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Diabetologia. 2012;55:2613-21.
12. Shi Z, Zhou M, Yuan B, Qi L, Dai Y, Luo Y, Holmboe-Ottesen G. Iron intake and body iron stores, anaemia and risk of hyperglycaemia among Chinese adults: the prospective Jiangsu Nutrition Study (JIN). Public Health Nutr. 2010;13:1319-27.
13. Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, et al. Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med. 2005;352:1769-78.
14. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese, normal-weight individual revisited. Diabetes. 1998;47:699-713.
15. Ye X, Yu Z, Li H, Franco OH, Liu Y, Lin X. Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol. 2007;49:1798-805.
16. Rajpathak SN, Wylie-Rosett J, Gunter MJ, Negassa A, Kabat GC, Rohan TE, Crandall J. Biomarkers of body iron stores and risk of developing type 2 diabetes. Diabetes Obes Metab. 2009;11:472-9.
17. Jehn ML, Guallar E, Clark JM, Couper D, Duncan BB, Ballantyne CM, Hoogeveen RC, Harris ZL, Pankow JS. A prospective study of plasma ferritin level and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 2007;165:1047-54.
18. Le TD, Bae S, Ed Hsu C, Singh KP, Blair SN, Shang N. Effects of cardiorespiratory fitness on serum ferritin concentration and incidence of type 2 diabetes: evidence from the Aerobics Center Longitudinal Study (ACLS). Rev Diabet Stud. 2008;5:245-52.
19. Zhao Z, Li S, Liu G, Yan F, Ma X, Huang Z, Tian H. Body iron stores and heme-iron intake in relation to risk of type 2 diabetes: a systematic review and meta-analysis. PLoS ONE. 2012;7:e41641.
20. Bao W, Rong Y, Rong S, Liu L. Dietary iron intake, body iron stores, and the risk of type 2 diabetes: a systematic review and meta-analysis. BMC Med. 2012;10:119.
21. Zong G, Zhu J, Sun L, Ye X, Jin Q, Zheng H, Yu Z, Li H, Sun Q, Lin X. Associations of fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in middle-aged and older Chinese. Am J Clin Nutr. 2013;98:319-26.
22. Wang J, Li H, Franco OH, Yu Z, Liu Y, Lin X. Adiponectin and metabolic syndrome in middle-aged and elderly Chinese. Obesity (Silver Spring). 2008;16:172-8.
23. Pan A, Ye X, Franco OH, Li H, Yu Z,Wang J, Qi Q, Gu W, Pang X, Liu H, et al. The association of depressive symptoms with inflammatory factors and adipokines in middle-aged and older Chinese. PLoS ONE. 2008;3:e1392.
24. Sun L, Franco OH, Hu FB, Cai L, Yu Z, Li H, Ye X, Qi Q, Wang J, Pan A, et al. Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese. J Clin Endocrinol Metab. 2008;93:4690-6.
25. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008-12.
26. Fumeron F, Pean F, Driss F, Balkau B, Tichet J, Marre M, Grandchamp B. Ferritin and transferrin are both predictive of the onset of hyperglycemia in men and women over 3 years: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study. Diabetes Care. 2006;29:2090-4.
27. Salomaa V, Havulinna A, Saarela O, Zeller T, Jousilahti P, Jula A, Muenzel T, Aromaa A, Evans A, Kuulasmaa K, et al. Thirty-one novel biomarkers as predictors for clinically incident diabetes. PLoS ONE. 2010;5:e10100.
28. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [cited 2012 Oct]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
29. Skov T, Deddens J, Petersen MR, Endahl L. Prevalence proportion ratios: estimation and hypothesis testing. Int J Epidemiol. 1998;27:91-5. 30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88.
31. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-60.
32. van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med. 2002;21:589-624.
33. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
34. Harrell FE. Regression modeling strategies with applications to linear models, logistic regression and survival analysis. New York: Springer-Verlag; 2001.
35. Orsini N, Bellocco R, Greenland S. Generalised least squares for trend estimation of summarized dose-response data. Stata J. 2006;6:40-57.
36. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood. 2002;99:3505-16.
37. Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol. 2009; 104:861-7.
38. Nannipieri M, Gonzales C, Baldi S, Posadas R, Williams K, Haffner SM, Stern MP, Ferrannini E. Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City Diabetes study. Diabetes Care. 2005;28:1757-62.
39. Kim CW, Chang Y, Sung E, Shin H, Ryu S. Serum ferritin levels predict incident non-alcoholic fatty liver disease in healthy Korean men. Metabolism. 2012;61:1182-8.
40. Iwasaki T, Nakajima A, Yoneda M, Yamada Y, Mukasa K, Fujita K, Fujisawa N, Wada K, Terauchi Y. Serum ferritin is associated with visceral fat area and subcutaneous fat area. Diabetes Care. 2005;28: 2486-91.
41. Eaton JW, Qian M. Molecular bases of cellular iron toxicity. Free Radic Biol Med. 2002;32:833-40.
42. Rahier J, Loozen S, Goebbels RM, AbrahemM. The haemochromatotic human pancreas: a quantitative immunohistochemical and ultrastructural study. Diabetologia. 1987;30:5-12.
43. Wilson JG, Lindquist JH, Grambow SC, Crook ED, Maher JF. Potential role of increased iron stores in diabetes. Am J Med Sci. 2003;325: 332-9.
44. Ferrannini E. Insulin resistance, iron, and the liver. Lancet. 2000;355: 2181-2.
45. Niederau C, Berger M, Stremmel W, Starke A, Strohmeyer G, Ebert R, Siegel E, Creutzfeldt W. Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia. 1984; 26:441-4.
46. Huang J, Jones D, Luo B, Sanderson M, Soto J, Abel ED, Cooksey RC, McClain DA. Iron overload and diabetes risk: a shift from glucose to Fatty Acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis. Diabetes. 2011;60:80-7.
47. Green A, Basile R, Rumberger JM. Transferrin and iron induce insulin resistance of glucose transport in adipocytes. Metabolism. 2006;55: 1042-5.
48. Vega S, Benito-Leon J, Bermejo-Pareja F, Medrano MJ, Vega-Valderrama LM, Rodriguez C, Louis ED. Several factors influenced attrition in a population-based elderly cohort: neurological disorders in Central Spain Study. J Clin Epidemiol. 2010;63:215-22.
49. Zunzunegui MV, Beland F, Gutierrez-Cuadra P. Loss to follow-up in a longitudinal study on aging in Spain. J Clin Epidemiol. 2001;54: 501-10.
50. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987;9:1-30.